Current and emerging rapid diagnostic technologies for differentiating bacterial and viral infections, including molecular assays, rapid antigen tests, biomarker-based diagnostics, host-response platforms, hematologic methods, and artificial intelligence-based decision-support systems are examined.
Abstract
Antimicrobial resistance (AMR) is a growing global health threat driven in part by inappropriate and unnecessary antibiotic use resulting from diagnostic uncertainty at the point of care. In outpatient and acute-care settings, clinicians are often unable to rapidly distinguish between viral and bacterial infections, leading to empiric antibiotic prescribing that contributes to the emergence and spread of resistant pathogens. This review examines current and emerging rapid diagnostic technologies for differentiating bacterial and viral infections, including molecular assays, rapid antigen tests, biomarker-based diagnostics, host-response platforms, hematologic methods, and artificial intelligence-based decision-support systems. These technologies are evaluated based on diagnostic accuracy, turnaround time, cost, accessibility, and clinical actionability within real-world healthcare settings. Although several emerging and point-of-care (POC) technologies can provide results within approximately 6–15 min, their ability to consistently align with the timing, workflow, and clinical decision-making requirements of frontline outpatient and emergency-care settings remains variable and incompletely established. Future progress in antimicrobial stewardship will depend on developing rapid, clinically actionable diagnostic systems that integrate seamlessly into patient care and reduce unnecessary antibiotic use.
ASPIRE workflow is a novel, cutting-edge, rapid, and universal Sepsis diagnostic workflow that can identify pathogens and characterize their AMR, directly from whole blood within a clinically actionable TAT, within 6 to 8 hours using nanopore sequencing.
Ramya Vm, T. Hall, D. Sharma et al.· Clinical Chemistry· 0 citations
Point-of-care testing (POCT) has emerged as an indispensable diagnostic strategy for addressing the increasing global burden of infectious diseases and the worsening threat of antimicrobial resistance. Owing to prominent advantages such as rapid detection of infectious agents, portability, and ease of accessibility, PO...
Quan Fang, Yu-Yan Lin, Gui-Xue Hu et al.· Frontiers in Microbiology· 0 citations
Syndromic testing, defined as the simultaneous nucleic acid amplification-based detection of multiple potential pathogens and antimicrobial resistance (AMR) determinants directly from clinical specimens, has transformed laboratory diagnosis of infectious diseases in the United States over the past two decades. In contr...
ABSTRACT Differentiating between bacterial and viral infections is essential in the emergency department (ED) to guide appropriate antibiotic treatment. Recent assays, such as the Food and Drug Administration (FDA)-cleared MeMed BV assay, can help with this distinction. The MeMed BV assay measures three host immune pro...
Maria E. Sundaram, Taylor A. Wahlig, Sophie Arbefeville· Journal of Clinical Microbio...· 0 citations
Objective: to critically evaluate emerging technologies for antimicrobial resistance (AMR) detection in clinical microbiology, highlighting their applications, advantages, and limitations. Methodology: a systematic literature review was conducted following PRISMA guidelines. Searches were performed in the PubMed/MEDLIN...
Thaynara Da Silva Brilhante, Raquel Gadelha Rafael, Vittoria Gabriele Vasconcelos Martins et al.· Journal of Health & Biol...· 0 citations
It is argued that the decision to start, continue or stop antibiotics must remain basically clinical; that the detection of nucleic acids is not equivalent to the diagnosis of an infection; and that sample quality, colonization, contamination, off-panel pathogens and prior antibiotic exposure may mitigate the interpret...
V. Fihman, H. Jacquier, K. Razazi et al.· Journal of Antimicrobial Che...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.